339 related articles for article (PubMed ID: 9528973)
1. Lactogenic hormone-inducible phosphorylation and gamma-activated site-binding activities of Stat5b in primary rat Leydig cells and MA-10 mouse Leydig tumor cells.
Kanzaki M; Morris PL
Endocrinology; 1998 Apr; 139(4):1872-82. PubMed ID: 9528973
[TBL] [Abstract][Full Text] [Related]
2. Distinctive roles for prolactin and growth hormone in the activation of signal transducer and activator of transcription 5 in pancreatic islets of langerhans.
Brelje TC; Stout LE; Bhagroo NV; Sorenson RL
Endocrinology; 2004 Sep; 145(9):4162-75. PubMed ID: 15142985
[TBL] [Abstract][Full Text] [Related]
3. PRL-induced ERalpha gene expression is mediated by Janus kinase 2 (Jak2) while signal transducer and activator of transcription 5b (Stat5b) phosphorylation involves Jak2 and a second tyrosine kinase.
Frasor J; Barkai U; Zhong L; Fazleabas AT; Gibori G
Mol Endocrinol; 2001 Nov; 15(11):1941-52. PubMed ID: 11682625
[TBL] [Abstract][Full Text] [Related]
4. Regulation of signal transducer and activator of transcription (STAT) 5b activation by the temporal pattern of growth hormone stimulation.
Gebert CA; Park SH; Waxman DJ
Mol Endocrinol; 1997 Apr; 11(4):400-14. PubMed ID: 9092792
[TBL] [Abstract][Full Text] [Related]
5. EGF receptor-mediated, c-Src-dependent, activation of Stat5b is downregulated in mitogenically responsive hepatocytes.
Guren TK; Ødegård J; Abrahamsen H; Thoresen GH; Susa M; Andersson Y; Østby E; Christoffersen T
J Cell Physiol; 2003 Jul; 196(1):113-23. PubMed ID: 12767047
[TBL] [Abstract][Full Text] [Related]
6. An immunohistochemical approach to monitor the prolactin-induced activation of the JAK2/STAT5 pathway in pancreatic islets of Langerhans.
Brelje TC; Svensson AM; Stout LE; Bhagroo NV; Sorenson RL
J Histochem Cytochem; 2002 Mar; 50(3):365-83. PubMed ID: 11850439
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of hepatic signal transducer and activator of transcription 5b by GH is not altered by 3-methylcholanthrene.
Timsit YE; Riddick DS
Endocrinology; 2002 Sep; 143(9):3284-94. PubMed ID: 12193540
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone-induced tyrosyl phosphorylation and deoxyribonucleic acid binding activity of Stat5A and Stat5B.
Smit LS; Vanderkuur JA; Stimage A; Han Y; Luo G; Yu-Lee LY; Schwartz J; Carter-Su C
Endocrinology; 1997 Aug; 138(8):3426-34. PubMed ID: 9231797
[TBL] [Abstract][Full Text] [Related]
9. Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C.
Fernández L; Flores-Morales A; Lahuna O; Sliva D; Norstedt G; Haldosén LA; Mode A; Gustafsson JA
Endocrinology; 1998 Apr; 139(4):1815-24. PubMed ID: 9528967
[TBL] [Abstract][Full Text] [Related]
10. Termination of growth hormone pulse-induced STAT5b signaling.
Gebert CA; Park SH; Waxman DJ
Mol Endocrinol; 1999 Jan; 13(1):38-56. PubMed ID: 9892011
[TBL] [Abstract][Full Text] [Related]
11. Serine phosphorylation of GH-activated signal transducer and activator of transcription 5a (STAT5a) and STAT5b: impact on STAT5 transcriptional activity.
Park SH; Yamashita H; Rui H; Waxman DJ
Mol Endocrinol; 2001 Dec; 15(12):2157-71. PubMed ID: 11731617
[TBL] [Abstract][Full Text] [Related]
12. Characterization and cloning of STAT5 from IM-9 cells and its activation by growth hormone.
Silva CM; Lu H; Day RN
Mol Endocrinol; 1996 May; 10(5):508-18. PubMed ID: 8732682
[TBL] [Abstract][Full Text] [Related]
13. Cross-talk between janus kinase-signal transducer and activator of transcription (JAK-STAT) and peroxisome proliferator-activated receptor-alpha (PPARalpha) signaling pathways. Growth hormone inhibition of pparalpha transcriptional activity mediated by stat5b.
Zhou YC; Waxman DJ
J Biol Chem; 1999 Jan; 274(5):2672-81. PubMed ID: 9915797
[TBL] [Abstract][Full Text] [Related]
14. Dissociation of Janus kinase 2 and signal transducer and activator of transcription 5 activation after treatment of Nb2 cells with a molecular mimic of phosphorylated prolactin.
Coss D; Kuo CB; Yang L; Ingleton P; Luben R; Walker AM
Endocrinology; 1999 Nov; 140(11):5087-94. PubMed ID: 10537136
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone-regulated intracellular signaling in UMR 106 osteosarcoma cells.
Morales O; Lindgren U; Haldosén LA
J Bone Miner Res; 2000 Nov; 15(11):2284-90. PubMed ID: 11092411
[TBL] [Abstract][Full Text] [Related]
16. Effect of erythropoietin on Leydig cell is associated with the activation of Stat5 pathway.
Yamazaki T; Kanzaki M; Kamidono S; Fujisawa M
Mol Cell Endocrinol; 2004 Jan; 213(2):193-8. PubMed ID: 15062567
[TBL] [Abstract][Full Text] [Related]
17. Differentiation-dependent prolactin responsiveness and stat (signal transducers and activators of transcription) signaling in rat ovarian cells.
Russell DL; Richards JS
Mol Endocrinol; 1999 Dec; 13(12):2049-64. PubMed ID: 10598581
[TBL] [Abstract][Full Text] [Related]
18. Role of cyclophilin B in prolactin signal transduction and nuclear retrotranslocation.
Rycyzyn MA; Reilly SC; O'Malley K; Clevenger CV
Mol Endocrinol; 2000 Aug; 14(8):1175-86. PubMed ID: 10935542
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone, but not prolactin, maintains, low-level activation of STAT5a and STAT5b in female rat liver.
Choi HK; Waxman DJ
Endocrinology; 1999 Nov; 140(11):5126-35. PubMed ID: 10537141
[TBL] [Abstract][Full Text] [Related]
20. Activation of the signal transducers and activators of transcription signaling pathway by growth hormone (GH) in skin fibroblasts from normal and GH binding protein-positive Laron Syndrome children.
Freeth JS; Silva CM; Whatmore AJ; Clayton PE
Endocrinology; 1998 Jan; 139(1):20-8. PubMed ID: 9421393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]